Endocrinology Research and Practice
Case Report

Tamoxifen Treatment for Riedel’s Thyroiditis: A Case Report

1.

Division of Internal Medicine, Department of Endocrinology and Metabolism, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey

2.

Department of Internal Medicine, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey

Endocrinol Res Pract 2023; 27: 245-247
DOI: 10.5152/erp.2023.22015
Read: 361 Downloads: 149 Published: 06 October 2023

Riedel’s thyroiditis is a rare variant of thyroiditis, and treatment recommendations are based on case reports. This thyroiditis form is considered among immunoglobulin G4-related diseases. Intense fibrosis of the thyroid gland can cause compression of the surrounding tissues and hypothyroidism. Glucocorticoids are recommended as first-line therapy, and tamoxifen is second-line therapy. Other immunosuppressive agents have also been used in some resistant cases. Our case was presented with a palpable firm mass in the neck, shortness of breath, and hypothyroidism. The exact diagnosis of Riedel’s thyroiditis was made after a pathological examination of a true-cut biopsy. We present the successful management of this case with glucocorticoid and tamoxifen combination treatment.

Cite this article as: Karakılıç E, Saygılı ES, Yildiz O, Kuyucu A. Tamoxifen treatment for Riedel’s thyroiditis: A case report. Endocrinol Res Pract. 2023;27(4):245-247.

Files
EISSN 2822-6135